Enterobacter aerogenes and Enterobacter cloacae; Versatile bacterial pathogens confronting antibiotic treatment

Frontiers in Microbiology

Volumn 6, Issue MAY, 2015, Pages

  Davin Regli, Anne ^a   Pagès, Jean Marie ^a  

^a AIX MARSEILLE UNIVERSITY   (France)

Author keywords

Enterobacter aerogenes; Enterobacter cloacae; Membrane and transporters; Regulation; Resistance mechanisms

Indexed keywords

AMOXICILLIN; AMPICILLIN; BETA LACTAM ANTIBIOTIC; BETA LACTAMASE; CARBAPENEM; CEFOXITIN; CEPHALOSPORIN; IMIPENEM; OUTER MEMBRANE PROTEIN; OUTER MEMBRANE PROTEIN F; OUTER MEMBRANE PROTEIN X; PORIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; UNCLASSIFIED DRUG;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; CELL MEMBRANE PERMEABILITY; EFFUSION; ENTEROBACTER AEROGENES; ENTEROBACTER CLOACAE; ENVIRONMENTAL STRESS; GENE MUTATION; HEALTH CARE FACILITY; HOSPITAL INFECTION; HUMAN; MICROBIAL COLONIZATION; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; OXIDATIVE STRESS; PROTEIN EXPRESSION; PROTEIN SYNTHESIS REGULATION; REVIEW; SEPTIC SHOCK;

BACTERIA (MICROORGANISMS); ENTEROBACTER; ENTEROBACTER AEROGENES; ENTEROBACTER CLOACAE; ENTEROBACTER SP.; KLEBSIELLA PNEUMONIAE; NEGIBACTERIA;

EID: 84931264872     PISSN: None     EISSN: 1664302X     Source Type: Journal    
DOI: 10.3389/fmicb.2015.00392     Document Type: Review

References (108)

1. Alekshun, M. N., and Levy, S. B. (2007). Molecular mechanisms of antibacterial multidrug resistance. Cell 128, 1037-1050. doi: 10.1016/j.cell.2007.03.004.
2. Allerberger, F., Koeuth, T., Lass-Florl, C., Dierich, M. P., Putensen, C., Schmutzhard, E., et al. (1996). Epidemiology of infections due to multiresistant Enterobacter aerogenes in an university hospital. Eur. J. Clin. Microbiol. Infect. Dis. 15, 517-521. doi: 10.1007/BF01691323.
3. Anastay, M., Lagier, E., Blanc, V., and Chardon, H. (2013). Epidémiologie des bêtalactamases à spectre étendu (BLSE) chez les entérobactéries dans un hôpital du sud de la France, 1997-2007. Pathol. Biol. 61, 38-43. doi: 10.1016/j.patbio.2012.03.001.
4. Arpin, C., Coze, C., Rogues, A. M., Gachie, J. P., Bebear, C., and Quentin, C. (1996). Epidemiological study of an outbreak due to multidrug-resistant Enterobacter aerogenes in a medical intensive care unit. J. Clin. Microbiol. 34, 2163-2169.
5. Arpin, C., Labia, R., Dubois, V., Noury, P., Souquet, M., and Quentin, C. (2002). TEM-80, a novel inhibitor-resistant β-lactamase in a clinical isolate of Enterobacter cloacae. Antimicrob. Agents Chemother. 46, 1183-1189. doi: 10.1128/AAC.46.5.1183-1189.2002.
6. Bertrand, X., Hocquet, D., Boisson, K., Siebor, E., Plésiat, P., and Talon, D. (2003). Molecular epidemiology of Enterobacteriaceae producing extended-spectrum β-lactamase in a French university-affiliated hospital. Int. J. Antimicrob. Agents 22, 128-133. doi: 10.1016/S0924-8579(03)00098-0.
7. Biendo, M., Canarelli, B., Thomas, D., Rousseau, F., Hamdad, F., Adjide, C., et al. (2008). Successive emergence of extended-spectrum-β-lactamase-producing and carbapenemase-producing Enterobacter aerogenes isolates in a university hospital. J. Clin. Microbiol. 46, 1037-1044. doi: 10.1128/JCM.00197-07.
8. Bornet, C., Davin-Regli, A., Bosi, C., Pagès, J. M., and Bollet, C. (2000). Imipenem resistance of Enterobacter aerogenes mediated by outer membrane permeability. J. Clin. Microbiol. 38, 1048-1052.
9. Bornet, C., Saint, N., Fetnaci, L., Dupont, M., Davin-Régli, A., Bollet, C., et al. (2004). Omp35, a new Enterobacter aerogenes porin involved in selective susceptibility to cephalosporins. Antimicrob. Agents Chemother. 48, 2153-2158. doi: 10.1128/AAC.48.6.2153-2158.2004.
10. Bosi, C., Davin-Regli, A., Bornet, C., Malléa, M., Pagès, J. M., and Bollet, C. (1999). Most Enterobacter aerogenes strains in France belong to a prevalent clone. J. Clin. Microbiol. 37, 2165-2169.
11. Boucher, H. W., Talbot, G. H., Bradley, J. S., Edwards, J. E., Gilbert, D., Rice, L. B., et al. (2009). Bad bugs, no drugs: no ESKAPE! an update from the Infectious Diseases Society of America. Clin. Infect. Dis. 48, 1-12. doi: 10.1086/595011.
12. Carbonne, A., Arnaud, I., Maugat, S., Marty, N., Dumartin, C., Bertrand, X., et al. (2013). National multidrug-resistant bacteria (MDRB) surveillance in France through the RAISIN network: a 9 year experience. J. Antimicrob. Chemother. 68, 954-959. doi: 10.1093/jac/dks464.
13. Charrel, R. N., Pagès, J. M., De Micco, P., and Malléa, M. (1996). Prevalence of outer membrane porin alteration in β-lactam-antibiotic-resistant Enterobacter aerogenes. Antimicrob. Agents Chemother. 40, 2854-2858.
14. Chevalier, J., Malléa, M., and Pagès, J. M. (2000). Comparative aspects of the diffusion of norfloxacin, cefepime and spermine through the F porin channel of Enterobacter cloacae. Biochem. J. 348(Pt 1), 223-227. doi: 10.1042/0264-6021:3480223.
15. Chevalier, J., Mulfinger, C., Garnotel, E., Nicolas, P., Davin-Régli, A., and Pagès, J. M. (2008). Identification and evolution of drug efflux pump in clinical Enterobacter aerogenes strains isolated in 1995 and 2003. PLoS ONE 3:e3203. doi: 10.1371/journal.pone.0003203.
16. Chevalier, J., Pagès, J. M., and Malléa, M. (1999). In vivo modification of porin activity conferring antibiotic resistance to Enterobacter aerogenes. Biochem. Biophys. Res. Commun. 266, 248-251. doi: 10.1006/bbrc.1999.1795.
17. Chollet, R., Bollet, C., Chevalier, J., Malléa, M., Pagès, J. M., and Davin-Regli, A. (2002). mar operon involved in multidrug resistance of Enterobacter aerogenes. Antimicrob. Agents Chemother. 46, 1093-1097. doi: 10.1128/AAC.46.4.1093-1097.2002.
18. Chollet, R., Chevalier, J., Bollet, C., Pagès, J. M., and Davin-Regli, A. (2004). RamA is an alternate activator of the multidrug resistance cascade in Enterobacter aerogenes. Antimicrob. Agents Chemother. 48, 2518-2523. doi: 10.1128/AAC.48.7.2518-2523.2004.
19. Corkill, J. E., Anson, J. J., and Hart, C. A. (2005). High prevalence of the plasmid-mediated quinolone resistance determinant qnrA in multidrug-resistant Enterobacteriaceae from the blood cultures in Liverpool, UK. J. Antimicrob. Chemother. 56, 1115-1117. doi: 10.1093/jac/dki388.
20. Dai, W., Sun, S., Yang, P., Huang, S., Zhang, X., and Zhang, L. (2013). Characterization of carbapenemases, extended spectrum β-lactamases and molecular epidemiology of carbapenem-non-susceptible Enterobacter cloacae in a Chinese hospital in ChongqinG. Infect. Genet. Evol. 14, 1-7. doi: 10.1016/j.meegid.2012.10.010.
21. Davin-Regli, A., Bolla, J. M., James, C. E., Lavigne, J. P., Chevalier, J., Garnotel, E., et al. (2008). Membrane permeability and regulation of drug "influx and efflux" in enterobacterial pathogens. Curr. Drug Targets 9, 750-759. doi: 10.2174/138945008785747824.
22. Davin-Regli, A., Monnet, D., Saux, P., Bosi, C., Charrel, R. N., Barthelemy, A., et al. (1996). Molecular epidemiology of Enterobacter aerogenes acquisition: one-year prospective study in two intensive care units. J. Clin. Microbiol. 34, 1474-1480.
23. Davin-Regli, A., and Pagès, J. M. (2012). Cross-resistance between biocides and antimicrobials: an emerging question. Rev. Sci. Tech. 31, 89-104.
24. Dé, E., Baslé, A., Jaquinod, M., Saint, N., Malléa, M., Molle, G., et al. (2001). A new mechanism of antibiotic resistance in Enterobacteriaceae induced by a structural modification of the major porin. Mol. Microbiol. 41, 189-198. doi: 10.1046/j.1365-2958.2001.02501.x.
25. De Champs, C., Sauvant, M. P., Chanal, C., Sirot, D., Gazuy, N., Malhuret, R., et al. (1989). Prospective survey of colonization and infection caused by expanded spectrum-beta-lactamase-producing members of the family Enterobacteriaceae in an intensive care unit. J. Antimicrob. Chemother. 27, 2887-2890.
26. De Gheldre, Y., Maes, N., Rost, F., De Ryck, R., Clevenbergh, P., Vincent, J. L., et al. (1997). Molecular epidemiology of an outbreak of multidrug-resistant Enterobacter aerogenes infections and in vivo emergence of imipenem resistance. J. Clin. Microbiol. 35, 152-160.
27. Diene, S. M., Merhej, V., Henry, M., El Filali, A., Roux, V., Robert, C., et al. (2013). The rhizome of the multidrug-resistant Enterobacter aerogenes genome reveals how new "killer bugs" are created because of a sympatric lifestyle. Mol. Biol. Evol. 30, 369-383. doi: 10.1093/molbev/mss236.
28. Doumith, M., Ellington, M. J., Livermore, D. M., and Woodford, N. (2009). Molecular mechanisms disrupting porin expression in ertapenem-resistant Klebsiella and Enterobacter spp. clinical isolates from the UK. J. Antimicrob. Chemother. 63, 659-667. doi: 10.1093/jac/dkp029.
29. Du, D., Wang, Z., James, N. R., Voss, J. E., Klimont, E., Ohene-Agyei, T., et al. (2014). Structure of the AcrAB-TolC multidrug efflux pump. Nature 509, 512-515. doi: 10.1038/nature13205.
30. Dugleux, G., Le Coutour, X., Hecquard, C., and Oblin, I. (1991). Septicemia caused by contaminated parenteral nutrition pouches: the refrigerator as an unusual cause. J. Parent. Ent. Nutr. 15, 474-475. doi: 10.1177/0148607191015004474.
31. Dumarche, P., De Champs, C., Sirot, D., Chanal, C., Bonnet, R., and Sirot, J. (2002). TEM derivative-producing Enterobacter aerogenes strains: dissemination of a prevalent clone. Antimicrob. Agents Chemother. 46, 1128-1131. doi: 10.1128/AAC.46.4.1128-1131.2002.
32. Dupont, M., James, C. E., Chevalier, J., and Pagès, J. M. (2007). An early response to environmental stress involves regulation of OmpX and OmpF, two enterobacterial outer membrane pore-forming proteins. Antimicrob. Agents Chemother. 51, 3190-3198. doi: 10.1128/AAC.01481-06.
33. Farmer, J. J. III, Davis, B. R., Hickman-Brenner, F. W., McWorther, A., Huntley-Carter, G. P., Asbury, M. A., et al. (1985). Biochemical identification of new species and biogroups of Enterobacteriaceae isolated from clinical specimens. J. Clin. Microbiol. 21, 46-76.
34. Fata, F., Chittivelu, S., Tessler, S., and Kupper, Y. (1996). Gas gangrene of the arm due to Enterobacter cloacae in a neutropenic patient. South. Med. J. 89, 1095-1096. doi: 10.1097/00007611-199611000-00014.
35. Fernandez-Baca, V., Ballesteros, F., Hervas, J. A., Villalon, P., and Alberti, S. (2001). Molecular epidemiological typing of Enterobacter cloacae isolates from a neonatal intensive care unit: three-year prospective study. J. Hosp. Infect. 49, 173-182. doi: 10.1053/jhin.2001.1053.
36. Fernandez-Cuenca, F., Rodriguez-Martinez, J. M., Martinez-Martinez, J. M. and Pascual, J. M. (2006). In vivo selection of Enterobacter aerogenes with reduced susceptibility to cefepime and carbapenems associated with decreased expression of a 40 kDa outer membrane protein and hyperproduction of AmpC β-lactamase. Int. J. Antimicrob. Agents 27, 549-552. doi: 10.1016/j.ijantimicag.2006.01.005.
37. Freney, J., Husson, M. O., Gavini, F., Madier, S., Martra, A., Izard, D., et al. (1988). Susceptibility to antibiotics and antiseptics of new species of the family Enterobacteriaceae. Antimicrob. Agents Chemother. 32, 873-876. doi: 10.1128/AAC.32.6.873.
38. Galani, I., Souli, M., Chryssouli, Z., Orlandou, K., and Giamarellou, H. (2005). Characterization of a new integron containing, bla (VIM-1) and aac(6')-IIc in an Enterobacter cloacae clinical isolate from Greece. J. Antimicrob. Chemother. 55, 634-638. doi: 10.1093/jac/dki073.
39. Galas, M., Decousser, J.-W., Breton, N., Godard, T., Allouch, T., Pina, P., et al. (2008). Nationwide study of the prevalence, characteristics, and molecular epidemiology of extended-spectrum-β-lactamase-producing Enterobacteriaceae in France. Antimicrob. Agents Chemother. 52, 786-789. doi: 10.1128/AAC.00906-07.
40. Gayet, S., Chollet, R., Molle, G., Pagès, J. M., and Chevalier, J. (2003). Modification of outer membrane protein profile and evidence suggesting an active drug pump in Enterobacter aerogenes clinical strains. Antimicrob. Agents Chemother. 47, 1555-1559. doi: 10.1128/AAC.47.5.1555-1559.2003.
41. Georghiou, P. R., Hamill, R. J., Wright, C. E., Versalovic, J., Koeuth, T. T., and Lupski, J. R. (1995). Molecular epidemiology of infections due to Enterobacter aerogenes: identification of hospital outbreak-associated strains by molecular techniques. Clin. Infect. Dis. 20, 84-94. doi: 10.1093/clinids/20.1.84.
42. Grattard, F., Pozzetto, B., Tabard, L., Petit, M., Ros, A., and Gaudin, O. G. (1995). Characterization of nosocomial strains of Enterobacter aerogenes by arbitrarily primed PCR analysis and ribotyping. Infect. Control Hosp. Epidemiol. 16, 224-230. doi: 10.2307/30140982.
43. Hajjar, E., Bessonov, A., Molitor, A., Kumar, A., Mahendran, K. R., Winterhalter, M., et al. (2010a). Toward screening for antibiotics with enhanced permeation properties through bacterial porins. Biochemistry 49, 6928-6935. doi: 10.1021/bi100845x.
44. Hajjar, E., Mahendran, K. R., Kumar, A., Bessonov, A., Petrescu, M., Weingart, H., et al. (2010b). Bridging timescales and length scales: from macroscopic flux to the molecular mechanism of antibiotic diffusion through porins. Biophys. J. 98, 569-575. doi: 10.1016/j.bpj.2009.10.045.
45. Hammami, S., Boutiba-Ben Boubaker, I., Saidani, M, Lakhal, E., Ben Hassen, A., Kamoun, A., et al. (2012). Characterization and molecular epidemiology of extended spectrum beta-lactamase producing Enterobacter cloacae isolated from a Tunisian hospital. Microb. Drug Resist. 18, 59-65. doi: 10.1089/mdr.2011.0074.
46. Hamprecht, A., Poirel, L., Gottig, S., Seifert, H., Kaase, M., and Nordmann P. (2013). Detection of the carbapenemase GIM-1 in Enterobacter cloacae in Germany. J. Antimicrob. Chemother. 68, 558-561. doi: 10.1093/jac/dks447.
47. He, G. X., Thorpe, C., Walsh, D., Crow, R., Chen, H., Kumar, S., et al. (2011). EmmdR, a new member of the MATE family of multidrug transporters, extrudes quinolones from Enterobacter cloacae. Arch. Microbiol. 193, 759-765. doi: 10.1007/s00203-011-0738-1.
48. Huang, S., Dai, W., Sun, S., Zhang, X., and Zhang, L. (2012). Prevalence of plasmid-mediated quinolone resistance and aminoglycoside resistance determinants among carbapeneme non-susceptible Enterobacter cloacae. PLoS ONE 7:e47636. doi: 10.1371/journal.pone.0047636.
49. Izdebski, R., Baraniak, A., Herda, M., Fiett, J., Bonten, M. J., Carmeli, Y., et al. (2014). MLST reveals potentially high-risk international clones of Enterobacter cloacae. J. Antimicrob. Chemother. 70, 48-56. doi: 10.1093/jac/dku359.
50. Jalaluddin, S., Devaster, J. M., Scheen, R., Gerard, M., and Butzler, J. P. (1998). Molecular epidemiological study of nosocomial Enterobacter aerogenes isolates in a Belgian hospital. J. Clin. Microbiol. 36, 1846-1852.
51. James, C. E., Mahendran, K. R., Molitor, A., Bolla, J. M., Bessonov, A. N., Winterhalter, M., et al. (2009). How beta-lactam antibiotics enter bacteria: a dialogue with the porins. PLoS ONE 4:e5453. doi: 10.1371/journal.pone.0005453.
52. Jarlier, V., and INVS. (2014). Surveillance of Multidrug Resistant Bacteria in French Healthcare Facilities BMR-Raisin Network Données 2012. Saint-Maurice: Institut de Veille Sanitaire. Available at: http://www.invs.sante.fr.
53. Jaskulski, M. R., Medeiros, B. C., Borges, J. V., Zalewsky, R., Fonseca, M. E., Marinowic, D. R., et al. (2013). Assessment of extended-spectrum β-lactamase, KPC carbapenemase and porin resistance mechanisms in clinical samples of Klebsiella pneumoniae and Enterobacter spp. Int. J. Antimicrob. Agents 42, 76-79. doi: 10.1016/j.ijantimicag.2013.03.009.
54. Kanamori, H., Hisakasu, Y., Yoichi, H., H Ayako, H., Kazuaki, A., Kunishima, H., et al. (2012). Molecular characteristics of extended-spectrum β-lactamases and qnr determinants in Enterobacter species from Japan. PLoS ONE 7:e37967. doi: 10.1371/journal.pone.0037967.
55. Khajuria, A., Praharaj, A. K., Kumar, M., and Grover, N. (2014). Carbapenem resistance among Enterobacter species in a tertiary care hospital in central India. Chemother. Res. Pract. 2014:972646. doi: 10.1155/2014/972646.
56. Kim, S. Y., Park, Y. J., Yu, J. K., Kim, Y. S., and Han, K. (2009). Prevalence and characteristics of aac(6')-Ib-cr in AmpC-producing Enterobacter cloacae, Citrobacter freundii, and Serratia marcescens: a multicenter study from Korea. Diagn. Microbiol. Infect. Dis. 63, 314-318. doi: 10.1016/j.diagmicrobio.2008.11.016.
57. Langley, J. M., Hanakowski, M., and Leblanc, J. C. (2001). Unique epidemiology of nosocomial urinary tract infection in children. Am. J. Infect. Control 29, 94-98. doi: 10.1067/mic.2001.111537.
58. Lavigne, J. P., Sotto, A., Nicolas-Chanoine, M. H., Bouziges, N., Bourg, G., Davin-Regli, A., et al. (2012). Membrane permeability, a pivotal function involved in antibiotic resistance and virulence in Enterobacter aerogenes clinical isolates. Clin. Microbiol. Infect. 18, 539-545. doi: 10.1111/j.1469-0691.2011.03607.x.
59. Lavigne, J. P., Sotto, A., Nicolas-Chanoine, M. H., Bouziges, N., Pagès, J. M., and Davin-Regli, A. (2013). An adaptive response of Enterobacter aerogenes to imipenem: regulation of porin balance in clinical isolates. Int. J. Antimicrob. Agents 41, 130-136. doi: 10.1016/j.ijantimicag.2012.10.010.
60. Lawler, A. J., Ricci, V., Busby, S. J., and Piddock, L. J. (2013). Genetic inactivation of acrAB or inhibition of efflux induces expression of ramA. J. Antimicrob. Chemother. 68, 1551-1557. doi: 10.1093/jac/dkt069.
61. Lee, E. H., Collatz, E., Trias, J., and Gutmann, L. (1992). Diffusion of β-lactam antibiotics into proteoliposomes reconstituted with outer membranes of isogenic imipenem-susceptible and-resistant strains of Enterobacter cloacae. J. Gen. Microbiol. 138, 2347-2351. doi: 10.1099/00221287-138-11-2347.
62. Lee, H. K., Park, Y. J., Kim, J. Y., Chang, E., Cho, S. G., Chae, H. S., et al. (2005). Prevalence of decreased susceptibility to carbapenems among Serratia marcescens, Enterobacter cloacae, and Citrobacter freundii and investigation of carbapenemases. Diagn. Microbiol. Infect. Dis. 52, 331-336. doi: 10.1016/j.diagmicrobio.2005.04.012.
63. Lee, S. H., Jeong, S. H., and Park, Y. M. (2003). Characterization of blaCMY-10 a novel, plasmid-encoded AmpC-type β-lactamase gene in a clinical isolate of Enterobacter aerogenes. J. Appl. Microbiol. 95, 744-752. doi: 10.1046/j.1365-2672.2003.02040.x.
64. Levy, S. B. (2002). Active efflux, a common mechanism for biocide and antibiotic resistance. Symp. Ser. Soc. Appl. Microbiol. 92, 65S-71S. doi: 10.1046/j.1365-2672.92.5s1.4.x.
65. Malléa, M., Chevalier, J., Bornet, C. E., Eyraud, A., Davin-Regli, A., Bollet, C., et al. (1998). Porin alteration and active efflux: two in vivo drug resistance strategies used by Enterobacter aerogenes. Microbiology 144, 3003-3009. doi: 10.1099/00221287-144-11-3003.
66. Malléa, M., Simonet, V., Lee, E. H., Gervier, R., Collatz, E., Gutmann, L., et al. (1995). Biological and immunological comparisons of Enterobacter cloacae and Escherichia coli porins. FEMS Microbiol. Lett. 129, 273-279. doi: 10.1016/0378-1097(95)00171-Z.
67. Martins, A., Spengler, G., Martins, M., Rodrigues, L., Viveiros, M., Davin-Regli, A., et al. (2010). Physiological characterisation of the efflux pump system of antibiotic-susceptible and multidrug-resistant Enterobacter aerogenes. Int. J. Antimicrob. Agents 36, 313-318. doi: 10.1016/j.ijantimicag.2010.06.036.
68. Masi, M., and Pagès, J. M. (2013). Structure, function and regulation of outer membrane proteins involved in drug transport in Enterobactericeae: the OmpF/C-TolC case. Open Microbiol. J. 7, 22-33. doi: 10.2174/1874285801307010022.
69. Masi, M., Pagès, J. M., and Pradel, E. (2006). Production of the cryptic EefABC efflux pump in Enterobacter aerogenes chloramphenicol-resistant mutants. J. Antimicrob. Chemother. 57, 1223-1226. doi: 10.1093/jac/dkl139.
70. Masi, M., Pagès, J. M., Villard, C., and Pradel, E. (2005). The eefABC multidrug efflux pump operon is repressed by H-NS in Enterobacter aerogenes. J. Bacteriol. 187, 3894-3897. doi: 10.1128/JB.187.11.3894-3897.2005.
71. Mezzatesta, M. L., Gona, F., and Stefani, S. (2012). Enterobacter cloacae complex: clinical impact and emerging antibiotic resistance. Future Microbiol. 7, 887-902. doi: 10.2217/fmb.12.61.
72. Miro, E., Alonso, C., Navarro, F., Mirelis, B., and Prats, G. (1995). Resistencia al imipenem en Enterobacter aerogenes. Enferm. Infecc. Microbiol. Clin. 13, 278-282.
73. Miró, E., Grünbaum, F., Gómez, L., Rivera, A., Mirelis, B., Coll, P., et al. (2013). Characterization of aminoglycoside-modifying enzymes in Enterobacteriaceae clinical strains and characterization of the plasmids implicated in their diffusion. Microb. Drug Resist. 19, 94-99. doi: 10.1089/mdr.2012.0125.
74. Nauciel, C., Philippon, A., Ronco, E., Pilliot, J., Guenounou, M., Paul, G., et al. (1985). Septicémies à Enterobacter cloacae et E. aerogenes: émergence de variants résistants. Presse Med. 14, 673-676.
75. Neuwirth, C., Siebor, E., Lopez, J., Pechinot, A., and Kazmierczak, A. (1996). Outbreak of TEM-24-producing Enterobacter aerogenes in an intensive care unit and dissemination of the extended-spectrum β-lactamase to other members of the family Enterobacteriacae. J. Clin. Microbiol. 34, 76-79.
76. Nikaido, H., and Pagès, J. M. (2012). Broad-specificity efflux pumps and their role in multidrug resistance of Gram-negative bacteria. FEMS Microbiol. Rev. 36, 340-363. doi: 10.1111/j.1574-6976.2011.00290.x.
77. Nordmann, P., Mariotte, S., Naas, T., Labia, R., and Nicolas, M. H. (1993). Biochemical properties of a carbapenem-hydrolyzing beta-lactamase from Enterobacter cloacae and cloning of the gene into Escherichia coli. Antimicrob. Agents Chemother. 37, 939-946. doi: 10.1128/AAC.37.5.939.
78. Pagès, J. M., James, C. E., and Winterhalter, M. (2008). The porin and the permeating antibiotic: a selective diffusion barrier in Gram-negative bacteria. Nat. Rev. Microbiol. 6, 893-903. doi: 10.1038/nrmicro1994.
79. Park, Y.-J., Yu, J.-K., Kim, S.-I., Lee, K., and Arakawa, Y. (2009). Accumulation of plasmid-mediated fluoroquinolone resistance genes, qepA and qnrS1, in Enterobacter aerogenes co-producing RmtB and Class A β-lactamase LAP-1. Ann. Clin. Lab. Sci. 39, 55-59.
80. Pérez, A., Canle, D., Latasa, C., Poza, M., Beceiro, A., Tomás Mdel, M., et al. (2007). Cloning, nucleotide sequencing, and analysis of the AcrAB-TolC efflux pump of Enterobacter cloacae and determination of its involvement in antibiotic resistance in a clinical isolate. Antimicrob. Agents Chemother. 51, 3247-3253. doi: 10.1128/AAC.00072-07.
81. Pérez, A., Poza, M., Aranda, J., Latasa, C., Medrano, F. J., Tomás, M., et al. (2012). Effect of transcriptional activators SoxS, RobA, and RamA on expression of multidrug efflux pump AcrAB-TolC in Enterobacter cloacae. Antimicrob. Agents Chemother. 56, 6256-6266. doi: 10.1128/AAC.01085-12.
82. Pestourie, N., Garnier, F., Barraud, O., Bedu, A., Ploy, M. C., and Mounier, M. (2014). Outbreak of AmpC β-lactamase-hyper-producing Enterobacter cloacae in a neonatal intensive care unit in a French teaching hospital. Am. J. Infect. Control 42, 456-458. doi: 10.1016/j.ajic.2013.11.005.
83. Piddock, L. J. (2006). Clinically relevant chromosomally encoded multidrug resistance efflux pumps in bacteria. Clin. Microbiol. Rev. 19, 382-402. doi: 10.1128/CMR.19.2.382-402.2006.
84. Pitout, J. D., Sanders, C. C., and Sanders, W. E. Jr. (1997). Antimicrobial resistance with focus on beta-lactam resistance in gram-negative bacilli. Am. J. Med. 103, 51-59. doi: 10.1016/S0002-9343(97)00044-2.
85. Pitout, J. D. D., Thomson, K. S., Hanson, N. D., Ehrhardt, A. F., Coudron, P., and Sanders, C. C. (1998). Plasmid-mediated resistance to expanded-spectrum cephalosporins among Enterobacter aerogenes strains. Antimicrob. Agents Chemother. 42, 596-600.
86. Poirel, L., Pitout, J. D., and Nordmann, P. (2007). Carbapenemases: molecular diversity and clinical consequences. Future Microbiol. 2, 501-512. doi: 10.2217/17460913.2.5.501.
87. Poirel, L., Van De Loo, M., Mammeri, H., and Nordmann, P. (2005). Association of plasmid-mediated quinolone resistance with extended-spectrum beta-lactamase VEB-1. Antimicrob. Agents Chemother. 49, 3091-3094. doi: 10.1128/AAC.49.7.3091-3094.2005.
88. Potron, A., Poirel, L., Rondinaud, E., and Nordmann, P. (2013). Intercontinental spread of OXA-48 β-lactamase-producing Enterobacteriaceae over a 11-year period, 2001 to 2011. Euro. Surveill. 18:20549. doi: 10.2807/1560-7917.ES2013.18.31.20549.
89. Pradel, E., and Pagès, J. M. (2002). The AcrAB-TolC efflux pump contributes to multidrug resistance in the nosocomial pathogen Enterobacter aerogenes. Antimicrob. Agents Chemother. 46, 2640-2643. doi: 10.1128/AAC.46.8.2640-2643.2002.
90. Preston, K. E., Radomski, C. C. A., and Venezia, R. A. (2000). Nucleotide sequence of the chromosomal ampC gene of Enterobacter aerogenes. Antimicrob. Agents Chemother. 44, 3158-3162. doi: 10.1128/AAC.44.11.3158-3162.2000.
91. Quiroga, M. P., Andres, P., Petroni, A., Soler Bistué, A. J., Guerriero, L., Vargas, L. J., et al. (2007). Complex class 1 integrons with diverse variable regions, including aac(6')-Ib-cr, and a novel allele, qnrB10, associated with ISCR1 in clinical enterobacterial isolates from Argentina. Antimicrob. Agents Chemother. 51, 4466-4470. doi: 10.1128/AAC.00726-07.
92. Raimondi, A., Traverso, A., and Nikaido, H. (1991). Imipenem-and meropenem-resistant mutants of Enterobacter cloacae and Proteus rettgeri lack porins. Antimicrob. Agents Chemother. 35, 1174-1180. doi: 10.1128/AAC.35.6.1174.
93. Rice, L. B. (2010). Progress, and challenges in implementing the research on ESKAPE pathogens. Infect. Control. Hosp. Epidemiol. Suppl. 1, S7-S10. doi: 10.1086/655995.
94. Robert, J., Pantel, A., Mérens, A., Lavigne, J. P., Nicolas-Chanoine, M. H., and ONERBA's Carbapenem Resistance Study Group. (2014). Incidence rates of carbapenemase-producing Enterobacteriaceae clinical isolates in France: a prospective nationwide study in 2011-12. J. Antimicrob. Chemother. 69, 2706-2712. doi: 10.1093/jac/dku208.
95. Sanders, W. E., and Sanders, C. C. (1997). Enterobacter spp.: pathogens poised to flourish at the turn of the century. Clin. Microbiol. Rev. 10, 220-241.
96. Song, E.-H., Park, K.-H., Jang, E.-Y., Lee, E.-J., Chong, Y.-P., Cho, O.-H., et al. (2010). Comparison of the clinical and microbiologic characteristics of patients with Enterobacter cloacae and Enterobacter aerogenes bacteremia: a prospective observation study. Diagnos. Microbiol. Infect. Dis. 66, 436-440. doi: 10.1016/j.diagmicrobio.2009.11.007.
97. Stoorvogel, J., van Bussel, M. J., Tommassen, J., and van de Klundert, J. A. (1991). Molecular characterization of an Enterobacter cloacae outer membrane protein (OmpX). J. Bacteriol. 173, 156-160.
98. Szabo, D., Melan, M. A., Hujer, A. M., Bonomo, R. A. Hujer, K. M., Bethel, C. R., et al. (2005). Molecular analysis of the simultaneous production of two SHV-type extended-spectrum beta-lactamases in a clinical isolate of Enterobacter cloacae by using single-nucleotide polymorphism genotyping. Antimicrob. Agents Chemother. 49, 4716-4720. doi: 10.1128/AAC.49.11.4716-4720.2005.
99. Thiolas, A., Bollet, C., La Scola, B., Raoult, D., and Pagès, J. M. (2005). Successive emergence of Enterobacter aerogenes strains resistant to imipenem and colistin in a patient. Antimicrob. Agents Chemother. 49, 1354-1358. doi: 10.1128/AAC.49.4.1354-1358.2005.
100. Thiolas, A., Bornet, C., Davin-Regli, A., Pagès, J. M., and Bollet, C. (2004). Resistance to imipenem, cefepime, and cefpirome associated with mutation in Omp36 osmoporin of Enterobacter aerogenes. Biochem. Biophys. Res. Commun. 317, 851-856. doi: 10.1016/j.bbrc.2004.03.130.
101. Torres, E., López-Cerero, L., Del Toro, M. D., and Pascual, A. (2014). First detection and characterization of an OXA-48-producing Enterobacter aerogenes isolate. Enferm. Infecc. Microbiol. Clin. 32, 469-470. doi: 10.1016/j.eimc.2013.10.008.
102. Tran, Q. T., Dupont, M., Lavigne, J. P., Chevalier, J., Pagès, J. M., Sotto, A., et al. (2009). Occurrence of efflux mechanism and cephalosporinase variant in a population of Enterobacter aerogenes and Klebsiella pneumoniae isolates producing extended-spectrum beta-lactamases. Antimicrob. Agents Chemother. 53, 1652-1656. doi: 10.1128/AAC.00822-08.
103. Valade, E., Davin-Regli, A., Bolla, J.-M., and Pagès, J.-M. (2013). "Bacterial membrane, a key for controlling drug influx and efflux," in Antibiotics: Targets, Mechanisms and Resistance, eds C. O. Gualerzi, L. Brandi, A. Fabbretti, and C. L. Pon (Weinheim: Wiley-VCH Verlag GmbH & Co. KGaA), 217-240. doi: 10.1002/9783527659685.ch9.
104. Veleba, M., De Majumdar, S., Hornsey, M., Woodford, N., and Schneiders, T. (2013). Genetic characterization of tigecycline resistance in clinical isolates of Enterobacter cloacae and Enterobacter aerogenes. J. Antimicrob. Chemother. 68, 1011-1018. doi: 10.1093/jac/dks530.
105. Vidal, S., Bredin, J., Pagès, J.-M., and Barbe, J. (2005). β-lactam screening by specific residues of the OmpF eyelet. J. Med. Chem. 48, 1395-400. doi: 10.1021/jm049652e.
106. Wang, S. A., Tokars, J. I., Bianchine, P. J., Carson, L. A., Arduino, M. J., Smith, A. L., et al. (2000). Enterobacter cloacae bloodstream infections traced to contamined human albumine. Clin. Infect. Dis. 30, 35-40. doi: 10.1086/313585.
107. Yigit, H., Anderson, G. J., Biddle, J. W., Steward, C. D., Rasheed, J. K., Valera, L. L., et al. (2002). Carbapenem resistance in a clinical isolate of Enterobacter aerogenes is associated with decreased expression of OmpF and OmpC porin analogs. Antimicrob. Agents Chemother. 46, 3817-3822. doi: 10.1128/AAC.46.12.3817-3822.2002.
108. Zaher, A., and Cimolai, N. (1997). ERIC-PCR typing profiles of Enterobacter cloacae are stable after development of advanced cephalosporin resistance. Int. J. Antimicrob. Agents 9, 165-167. doi: 10.1016/S0924-8579(97)00046-0.